The purpose of this study is to examine whether a low dose of CBD+THC will decrease the
frequency of convulsive seizures in adults with drug-resistant epilepsy, when used in
addition to standard anti-epileptic drugs (AEDs). This study will also study the genes
associated with epilepsy and whether different epileptic syndromes respond to treatment with
CBD+THC.
Phase:
Phase 3
Details
Lead Sponsor:
The Epilepsy Research Program of the Ontario Brain Institute
Collaborators:
London Health Sciences Centre MedReleaf Ontario Brain Institute University Health Network, Toronto University of Toronto